跳至主要内容
临床试验/CTRI/2022/11/047129
CTRI/2022/11/047129尚未招募4 期

Double blinded randomized Controlled Study Comparing the Efficacy and Tolerance of levocetrizine, Bilastine and Bepotastine in Patients with Urticaria.

Meenakshi medical college hospital and research institute0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1)Patients with diagnosis of urticaria (acute/chronic)
  • 2)Patients for whom documented consent has been obtained regarding their voluntary participation in this clinical study
  • 3) Patients aged 18 years or older at the time that they provide consent.
  • 4) Patient agrees not to take other treatments than those provided in the study.

排除标准

  • 1)pregnant and lactating females
  • 2)patients who are immunocompromised due to disease or drugs
  • 3) Patients with pruritis caused due to other cutaneous skin disorders.
  • 4) Patients with known hypersensitivity to antihistamines.
  • 5) Known case of Bronchial asthama / COPD.
  • 6) Patients with urticaria presenting with systemic signs/symptoms
  • 7) Patients with urticaria and angio oedema

研究者

发起方
Meenakshi medical college hospital and research institute

相似试验